Next Article in Journal
The Management of Neonates ≥34 Weeks’ Gestation at Risk of Early Onset Sepsis: A Pilot Study
Previous Article in Journal
The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy
Previous Article in Special Issue
Drug Utilization Evaluation and Impact of Pharmacist Interventions on Optimization of Piperacillin/Tazobactam Use: A Retrospective Analysis and Prospective Audit
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis

by
Ahmad Habeeb Hattab Dala Ali
1,2,*,
Sabariah Noor Harun
1,
Noordin Othman
3,4,*,
Baharudin Ibrahim
5,
Omer Elhag Abdulbagi
6,
Ibrahim Abdullah
4 and
Indang Ariati Ariffin
7
1
Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Penang 11800, Malaysia
2
Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia
3
Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah 42353, Saudi Arabia
4
School of Pharmacy, Management and Science University, University Drive, Off Persiaran Olahraga, Shah Alam 40100, Malaysia
5
Faculty of Pharmacy, University of Malaya, Wilayah Persekutuan Kuala Lumpur 50603, Malaysia
6
Department of Surgery, King Salman Medical City, Medina 42316, Saudi Arabia
7
Research Management Centre, Management and Science University, University Drive, Off Persiaran Olahraga, Section 13, Shah Alam 40100, Malaysia
*
Authors to whom correspondence should be addressed.
Antibiotics 2023, 12(8), 1305; https://doi.org/10.3390/antibiotics12081305
Submission received: 17 April 2023 / Revised: 15 June 2023 / Accepted: 20 June 2023 / Published: 10 August 2023
(This article belongs to the Special Issue Antimicrobial Use, Resistance and Stewardship, 2nd Volume)

Abstract

:
In the management of sepsis, providing adequate empiric antimicrobial therapy is one of the most important pillars of sepsis management. Therefore, it is important to evaluate the adequacy of empiric antimicrobial therapy (EAMT) in sepsis patients admitted to intensive care units (ICU) and to identify the determinants of inadequate EAMT. The aim of this study was to evaluate the adequacy of empiric antimicrobial therapy in patients admitted to the ICU with sepsis or septic shock, and the determinants of inadequate EAMT. The data of patients admitted to the ICU units due to sepsis or septic shock in two tertiary healthcare facilities in Al-Madinah Al-Munawwarah were retrospectively reviewed. The current study used logistic regression analysis and artificial neural network (ANN) analysis to identify determinants of inadequate empiric antimicrobial therapy, and evaluated the performance of these two approaches in predicting the inadequacy of EAMT. The findings of this study showed that fifty-three per cent of patients received inadequate EAMT. Determinants for inadequate EAMT were APACHE II score, multidrug-resistance organism (MDRO) infections, surgical history (lower limb amputation), and comorbidity (coronary artery disease). ANN performed as well as or better than logistic regression in predicating inadequate EAMT, as the receiver operating characteristic area under the curve (ROC-AUC) of the ANN model was higher when compared with the logistic regression model (LRM): 0.895 vs. 0.854. In addition, the ANN model performed better than LRM in predicting inadequate EAMT in terms of classification accuracy. In addition, ANN analysis revealed that the most important determinants of EAMT adequacy were the APACHE II score and MDRO. In conclusion, more than half of the patients received inadequate EAMT. Determinants of inadequate EAMT were APACHE II score, MDRO infections, comorbidity, and surgical history. This provides valuable inputs to improve the prescription of empiric antimicrobials in Saudi Arabia going forward. In addition, our study demonstrated the potential utility of applying artificial neural network analysis in the prediction of outcomes in healthcare research.

1. Introduction

Sepsis is considered a medical emergency that involves a systemic immunological response due to an infection, resulting in end-stage organ malfunction and death [1]. It has been reported as one of the major causes of morbidity and mortality in intensive care units (ICU) and is considered the most common death cause in non-coronary intensive care units, with a mortality rate of approximately 20–25% [2,3].
In managing sepsis, therapies are provided to manage the basic elements of sepsis, including the eradication of the underlying infection, the prevention and treatment of organ dysfunction, and host response [2]. Therefore, initial resuscitation through restoring the tissue perfusion and early empiric antimicrobial therapy are rendered among the pillars of sepsis management [4]. Several studies have demonstrated the significant association of inadequate EAMT with increased mortality in ICU sepsis patients [5,6,7,8]. Reasons for the inadequacy of EAMT include the resistance of the isolated microorganism to the provided empiric agents, the selection of empiric agents not according to the clinical practice guidelines, the dose of empiric agents not in accordance with the recommended dose by the guidelines, and delays in providing adequate EAMT [5,9]. This due to the fact that adequate empiric antimicrobial therapy is optimally selected to cover the causative pathogen and should also be provided at the optimal time; it also involves the avoidance of overdosing or under-dosing, i.e., for EAMT to be considered adequate it should include the correct agent and the right dose, and be administered in a timely manner [10]. The adequacy of EAMT provided to different sepsis patient populations, including ICU sepsis patients, surgical ICU sepsis patients, and sepsis patients admitted to medical and surgical wards, has been described by several studies worldwide [5,7,8,9,11,12]. Sepsis definition has evolved over the past decades, and therefore there are inconsistent applications of sepsis definitions which can potentially result in a variability of sepsis epidemiology in the literature [1,13]. In addition, the percentages of adequate empiric antimicrobial therapy reported in the literature varied (Figure 1). This can be due to the lack of a consistent definition of sepsis and adequate EAMT used in these studies [5,6,7,9,12,14,15,16,17,18]. There have been several studies conducted among ICU sepsis patients in Saudi Arabia. However, most of these studies focused on the spectrum and antimicrobial sensitivity of the bacteria pathogens in neonatal sepsis [19], the impact of empiric antimicrobial therapy on the mortality of septic shock patients with liver cirrhosis [20], and pediatric ICU patients [21]. In addition, there is a lack of evidence on the adequacy of empiric antimicrobials provided to ICU sepsis patients and their determinants in Middle Eastern countries [22].
Artificial Neural Network (ANN) possesses the ability to collect samples’ information, learn, make generalizations, and make decisions regarding samples that they have not seen before (i.e., test sets) by using previously learnt information (i.e., training sets) [23]. In addition, ANN models are considered a flexible, complex, non-linear modeling technique that possesses properties which are not found in other modeling systems, including a powerful performance in dealing patterns that are incomplete or noisy, and high fault tolerance [24]. Therefore, the artificial neural network is very useful when dealing with complex relationships and implicit interactions in the data [25].
The prediction of outcomes is an important aspect of healthcare research in the discipline of critical care, which demonstrates the potential utility of ANN analysis in such research disciplines [24]. In recent years, some researchers have used ANN and compared its performance with regression analysis. For instance, Fardamal and colleagues assessed the utility of ANN in the prediction of survival in breast cancer patients, and they reported that ANN was found to give a better performance in the prediction of survival when compared with logistic regression models (LRM), with AUC of 0.834 and 0.744, respectively [26]. Furthermore, ANN was found to possess a better performance when compared with LRM in the prediction of lower back pain [27]. However, there have been no studies utilizing such analysis (i.e., artificial neural network) in predicting the determinants of EAMT adequacy. Therefore, the aim of this study was to assess the adequacy of EAMT and the determinant of inadequate EAMT in ICU sepsis patients at Al-Madinah Al-Munawwarah. This study also utilized ANN analysis and compared its performance with traditional regression models, i.e., logistic regression models (LRM), in predicting the outcome of interest.

2. Results

In the current study, we screened a total of 1477 records of patients admitted to two centers (Medina General Hospital—King Salman Medical City, and Miqat General Hospital) from July 2019 to June 2021. A total of 292 patients were diagnosed with sepsis/septic shock, which makes the prevalence of sepsis/septic shock 19.8%. However, only 253 patients met our inclusion criteria and therefore were included in the study.
The mean age of the patients was 67.6 ± 15.1. Of the 253 patients, 61.7% of them were male and only 38.3% of them were female. Only 5.1% of patients were Hajj and Umrah visitors, while the remaining 94.9% were either citizens or residents. More than half of the patients (55.3%) were diagnosed with septic shock, while 44.7% of them were diagnosed with sepsis. The mean number of comorbidities was 2.3 ± 0.9, and the most frequently reported comorbidities were hypertension and diabetes mellitus, (84.6%) and (84.4%), respectively. More than half of the patients (56.9%) had a moderate GCS score (9–12). The mean score of the APACHE II scores was 27.1 ± 8.4. The majority of patients (70%) were admitted to the ICU from the emergency departments. The majority of patients (70.4%) developed sepsis/septic shock due to community-acquired infections. The most frequently reported source of infection was respiratory tract infections (45.8%). Thirty-four per cent of patients had had previous surgery, of which 20.6% had had the surgery within one week or during the ICU admission; lower limb amputation was the most common type of surgery. The mean number of organ failure incidence among our cohort was 3.5 ± 1.78. Almost thirty one percent of causative organisms (30.8%) were classified as multiple drug resistant microorganism (MRDO) infections (Table 1).
With regard to the adequacy of empiric antimicrobial therapy used in our cohort, more than half of the provided EAMT (53%) were found to be inadequate. The most common cause of inadequacy was the resistance of the isolated microorganism to the EAMT (24%), followed by a delay in providing the EAMT regimen (16%) (Figure 2).
According to the univariate regression analysis, potential determinants (i.e., risk factors) significantly associated with empiric antimicrobial therapy were age, diagnosis (septic shock), site which patients were admitted to the ICU from, surgical history, surgical intervention within the past week, type of surgery (lower limb amputation), day 1 GCS score, number of co-morbidities, type of co-morbidities (hypertension and coronary artery disease), need for mechanical ventilation, number of incidences of organ failure, type of organ failure (acute kidney injury, liver failure, cardiac failure, DIC, respiratory failure, and central nervous system insult), day 1 APACHE II score, type of infection (respiratory tract infection and soft tissue/skin infection), and MDRO infection Table S1.
However, the multivariate regression analysis revealed that patients who had coronary artery disease as a comorbidity significantly increased the odds of inadequate EAMT by 3.128 (OR 3.128, 95% CI 1.016–9.629, p = 0.047), with a higher APACHE II score (OR 1.087, 95% CI 1.010–1.170, p = 0.026), i.e., each one-unit increase in the APACHE score increased the odds of inadequate EAMT by 1.087, and MDRO infection was found to significantly increase the odds of inadequate EAMT by 7.318 (OR 7.318, 95% CI 2.839–18.864, p = <0.001). In contrast, patients who had surgical intervention (lower limb amputation) were found to be less likely to have inadequate EAMT, with an odds ratio of 0.019 (OR 0.019, 95% CI 0.025–0.478, p = 0.003); see Table 2.
The classification accuracy of the ANN outperformed the logistic regression model, as shown by (Table 3) the ANN training and testing sets’ accuracy for inadequate EAMT; 80.0% and 82.0%, respectively, while the logistic regression model was able to correctly classify inadequate EAMT by 76.1%. In addition, the overall percentage correct of prediction was found to be higher in the ANN model when compared with the logistic regression model (Table 3).
The Receiver Operating Characteristic (ROC) curve for inadequate EAMT for the ANN and logistic regression models were developed. The ANN model’s area under the curve (ROC-AUC) based on both training and testing samples was 0.895, indicating a very good classification accuracy rate; see Figure 3. Also, when compared with the ROC-AUC of the regression model, the ANN had a higher ROC-AUC: 0.895 vs. 0.845 (Figure 3 and Figure 4).
Table 4, below, indicates the determinants’ importance in the prediction of the inadequate EAMT. The APACHE II scores were found to be the most important determinant of inadequate EAMT (importance: 0.489; normalized importance: 100%), followed by MDRO infection (importance: 0.214; normalized importance: 43.9%), surgical history (importance: 0.160; normalized importance: 32.7%), and coronary artery disease (importance: 0.137; normalized importance: 28.0%).

3. Discussion

The percentage of inadequate empiric antimicrobial therapy in our cohort was 53%. Numerous studies in the literature that investigated the percentages of inadequate empiric antimicrobial therapy have shown inconsistent findings. These studies reported that inadequate EAMT was provided to 18.0%, 18.6%, and 11.0% of sepsis patients admitted to the ICU in United States [11], Norway [12], and France [15], respectively. Much higher percentages were reported in other countries; for example, in Tunisia (48.0%) [8], and 71.9% in Malaysia [5] and 41.1% in Austria [7]. This variation could be due to the inconsistency of the definition of EAMT’s adequacy used by these studies, as most studies defined the adequacy of EAMT according to the culture and sensitivity results, while several studies took into account the timing, dose, and compliance with the guideline recommendations when assessing the EAMT adequacy [28]. Furthermore, variations in the settings, infectious agents, and diseases could potentially impart a variation in the reported percentages of inadequate EAMT in the literature [22,28]. Such variations were also reported through a meta-analysis conducted by Kristel and colleagues, which reported that the percentages of inappropriate empiric antimicrobial therapy showed an enormous range, from 14.1 to 78.9%. However, out of the 27 studies included in the meta-analysis, 13 studies reported a percentage of inappropriate EAMT of 50% or more [28].
Several studies have indicated that providing inadequate empiric antimicrobial therapy can significantly result in poor clinical outcomes in sepsis patients [5,6,7,8]. This shows the importance of assessing the adequacy of EAMT and its determinants, as the decision of the selection of empiric antimicrobial therapy is very challenging, which indicates the importance of identifying the determinants of inadequate EAMT, which subsequently contributes significantly to the improvement of the rational use of antimicrobials [29]. With this in mind, according to the multivariate regression analysis of our study data, it revealed that factors significantly associated with inadequate EAMT were coronary artery disease as a comorbidity, a higher APACHE II score, and MDRO infection. On the other hand, patients with a surgical history of lower limb amputation were less likely to receive inadequate EAMT.
Within a similar context, similar results were obtained by other studies in the literature assessing the determinants of inadequate EAMT. For instance, a study conducted by Yokota et al. (2014) identified that the presence of polymicrobial infection and a higher APACHE II score were independently associated with inadequate antimicrobial therapy among patients with severe sepsis and septic shock. This can be explained as an underestimation of the patient’s severity of illness, i.e., neglecting the patient’s severity of illness can affect the decision to use optimal antimicrobial therapy [30]. Also, this could be due to the complexity of using severity of illness scoring systems, and the prolonged time needed for calculating the scores can include difficulties in using such scoring systems [31]. In addition, coronary artery disease (CAD) was associated with the increased likelihood of receiving inadequate EAMT. In this regard, Tirifi and colleagues (2018) also identified chronic co-morbidities (chronic respiratory failure) to be a significantly associated with the appropriateness of EAMT [8]. This also can be considered an implication of not including comorbidities in the APACHE II score. Therefore, it can be reflected as an under-estimation of patients’ severity of illness and can subsequently result in providing inadequate therapy [30,32,33]. In addition, one of the important strategies to ensure the adequacy of the provided therapy is to identify patients at high risk, which includes patients with nosocomial infection and co-morbidities [34].
The association of MDRO with inadequate empiric antimicrobial therapy was frequently identified by studies in the literature. For instance, according to a meta-analysis carried out by Carrara and colleagues (2018), multidrug resistant organisms were identified as being significantly associated with inappropriate empiric antibiotic treatment and with poor clinical outcomes [35]. MDRO infections remain one of the most commonly reported determinants of inadequate EAMT in both community- and hospital-acquired infections, as they have been reported to be one of the independent risk factors of inadequate EAMT in different critically ill patient populations, including patients with bacteremia [36] and patients admitted to the hospital due to urinary tract infections, pneumonia, and sepsis [37]. Moreover, risk factors for inappropriate empiric antimicrobial therapy were found to be similar to the identified risk factors for fluoroquinolones in a study including a hospitalized patient with urinary tract infections [38]. This shows the importance of the identification of independently associated modifiable and non-modifiable risk factors (i.e., predictors) of MDRO infections in sepsis patients, and the development of a scoring system for the early determination of the likelihood of patients to have an MDRO infection. In addition, taking into account the patients’ severity of illness, co-morbidities, and local epidemiologic data were important for developing rapid diagnostic tools to guide the clinicians in selecting the most appropriate and efficient antimicrobial therapy [39].
In our study, patients with a history of surgical procedures (limb amputation) were found to be significantly less likely to receive inadequate empiric antimicrobial therapy. Fitousis and colleagues reported in their study that appropriate empiric antimicrobial therapy was provided to 82% of patients admitted due to surgical sepsis, which reflected a successful implementation of the antimicrobial guidelines [11]. This can also reflect the adherence to the Saudi Ministry of Health National Antimicrobial Therapy Guidelines for Community- and Hospital-Acquired Infections in Adults recommendations [40]. This was also shown by a large, prospective study conducted in 150 intensive care units, which also reported that surgical intensive units were more likely to comply with the surviving sepsis campaign’s recommendations [41].
Compared with a traditional logistic regression model (LRM), the artificial neural network (ANN) model had a higher classification accuracy for inadequate EAMT compared with LRM, and the ROC-AUC of the ANN model was higher than LRM’s. Therefore, the ANN model performed as well as or better than the LRM model in predicting inadequate EAMT in sepsis patients. Similar results were reported by several studies that utilized ANN in the prediction of outcomes. The ROC-AUCs of ANN vs. LRM were reported to be 0.77 vs. 0.72, 0.75 vs. 0.72, and 0.97 vs. 0.95 in predicting lower-back-pain progression, ICU mortality, and thyroid disease diagnosis, respectively [25,27,42]. Given that the less error prediction model is considered a healthcare researcher’s ultimate goal, the utilization of an artificial neural network can potentially provide new opportunities to obtain predictions with enhanced accuracy [25]. This can explain the increasing trends of the utilization of ANN models making complex medical decisions and the prediction of outcomes in patients with various diseases [43].
According to the artificial neural network analysis, APACHE II score and MDRO infection were found to be the most important determinants of EAMT adequacy. To our knowledge, our study is the first of its kind to use an artificial neural network model to predict the EAMT adequacy in sepsis patients. Therefore, there is a lack of literature to compare. However, it is well established that the underestimation of a patient’s severity of illness subsequently affects the adequacy of EAMT and outcomes in sepsis patients, and this can explain why it is crucial to aim for the quick identification of the source of infection, and the fast administration of adequate EAMT when managing patients with sepsis [12,30]. In addition, empiric antimicrobial therapy should be carried out according to the patient’s risk factors, which include the location of the acquisition of infection, the site of the infection, the severity of the illness, the immune status, and the local antibiogram [44].
Evidently, multidrug-resistant organism infections were identified as being significantly associated with inappropriate empiric antibiotic treatment and with poor clinical outcomes [35]. Furthermore, according to a 4-year prospective study conducted by Corcione and colleagues, the introduction of empiric antimicrobial therapy manuals resulted in a decrease in the trends of antimicrobial use and MDRO blood stream infections [45]. This also shows that providing adequate empiric antimicrobial therapy will also lead to a reduction in the antimicrobial resistance, which shows the importance of determining the adequacy of EAMT and the determinants of inadequate EAMT.
Given that, the prediction of outcomes is rendered an important aspect of healthcare research in the discipline of critical care [24]. Our study demonstrated that artificial neural network analysis outperformed the regression analysis, i.e., having a higher accuracy and higher ROC-AUC. This supports the usefulness of artificial neural network models in the prediction of outcomes of interest and the potential utility of the application of deep learning and artificial intelligence methodologies in the prediction of healthcare research outcomes, potentially augmenting healthcare professionals’ capabilities [46].
This study has many strengths, which include being, to our knowledge, the first study that assesses the adequacy of empiric antimicrobial therapy in ICU sepsis patients and its predictors in Saudi Arabia. It is very challenging to make appropriate selections of adequate empiric antimicrobial therapy regimens. Therefore, providing inputs regarding inadequate antimicrobial therapy and its determinants contributes significantly to the improvement of the rational use of antimicrobials [29]. Thus, our study provides a valuable input that can be used by healthcare providers and healthcare institutes to improve empiric antimicrobial therapy prescription in the era of limited and lack of availability of new antimicrobial agents that can be used to overcome new resistant microorganisms [47]. Also, our study is the first of its kind that utilized deep learning and artificial intelligence methodologies in the prediction of inadequate EAMT. However, the current study also has some limitations, which includes the current study being conducted in a specific geographic region, i.e., Al-Madinah Al-Munawwarah. Therefore, the results of the current study should be used and interpreted with caution in practice settings outside Al-Madinah Al- Munawwarah. In addition, factors that can affect the pharmacokinetics of antimicrobials were not incorporated in this study. Thus, future research should include such parameters to evaluate the changes in antimicrobial pharmacokinetics in sepsis patients and their impact on the adequacy of EAMT provided to sepsis patients.

4. Materials and Methods

4.1. Study Design, Settings, and Populations

In this retrospective cohort observational study, medical records of all patients admitted to the intensive care units in Medina General Hospital and Miqat General Hospital from July 2019 to June 2021 were reviewed. Patients were included according to the following inclusion criteria: adult patients (>18 years old); admitted to the ICU; stayed at least 3 days in the ICU and not more than 14 days, and in case of multiple admissions, only the first admission was considered; and diagnosed with sepsis/septic shock according to the Sepsis—3 Definitions [48], where sepsis was defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock was defined as a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities were profound enough to substantially increase mortality. Exclusion criteria included COVID-19 patients, pregnant patients, patients with active malignancy, patients less than 18 years of age, and patients admitted to non-ICU wards.

4.2. Data Collection

All ICU admissions were reviewed from the intensive care unit admission/discharge record and statistics unit. Medical record numbers (MRNs) of patients diagnosed with sepsis or septic shock were collected. Then, based on the MRNs, data related to patients’ demographics, medical and surgical history, comorbidities, organ function, GCS score, APACHE II score, information related to onset and type of infection, and the provided EAMT were retrieved from the computerized medical records system (ALERT®).

4.3. Assessment of Empiric Antimicrobial Therapy (EAMT)’s Adequacy

The criteria of adequate empiric antibiotic therapy was developed and adapted after an extensive search of the literature [5,6,7,9,12,14,16,17,22,30,36,49,50,51]. The EAMT adequacy assessment criteria were reviewed by two experts (clinical pharmacy fellows) to ensure that the criteria would appropriately measure the purpose of the study (i.e., stratify EAMT into adequate or inadequate). Following that, to assess the applicability of the criteria, a set of 19 randomly selected cases diagnosed with sepsis or septic shock were evaluated by the experts. Inter-ratter agreement was evaluated using percent raw agreement and Cohen’s kappa (κ) statistic for the adequacy of EAMT. A kappa value with 95% confidence interval was reported to be 0.791 (0.415–0.919), which according to Landis and Koch [52] is considered substantial agreement. The strength of agreement is defined as kappa values less than zero correspond to no agreement, from zero to 0.2 correspond to slight agreement, from 0.21 to 0.4 correspond to fair agreement, from 0.41 to 0.6 correspond to moderate agreement, from 0.61 to 0.8 correspond to substantial agreement, and from 0.81 to 1 correspond to near-perfect agreement [52]. The following criteria were used in this study to describe adequate empiric antibiotic therapy: The isolated microorganisms were covered by at least one of the used empiric agents. The dose and frequency of the administered empiric antimicrobials were in accordance with local guidelines in Saudi Arabia and could cover the most likely causative pathogen depending on the site and source of infection [40]. Empiric antimicrobials had to be administered as soon as possible and not more than six hours, and the time of ICU admission and time of initiation of empiric agents were verified based on the patients’ records. In contrast, EAMT was considered inadequate if the empiric agents did not cover the isolated microorganisms, i.e., the isolated pathogen was not sensitive to any of the empiric agents used; the dose of empiric agents exceeded the guideline recommend dose according to the Creatinine clearance; there was escalation of empiric agents from narrow to broad or addition of other new combinations or agents used that were not recommended by the local guidelines; or any delay of EAMT or significant interactions.

4.4. Statistical Analysis

All statistical analyses were performed using Statistical Package for Social Sciences (SPSS, IBM Corp, Armonk, NY, USA), version 25.0 [53]. Descriptive statistics were used to describe the data; continuous data were presented as mean ± standard deviation (SD), and categorical data were expressed as numbers with percentages. The significance level was set at a p value of less than 0.05. To identify determinants of inadequate empiric antimicrobial therapy (EAMT), binary logistic regression analysis was used to identify statistically significant associated variables associated with inadequate EAMT. Multivariate regression analysis was used to identify the independently associated determinants of inadequate empiric antimicrobial therapy.
To develop ANN and to identify the importance of predictors, the multilayer perceptron function using Statistical Package for Social Sciences (SPSS), version 25.0 [53] was used to develop the ANN model of the outcome variables (i.e., Inadequate EAMT). Multiple regression analysis was used to determine the input variables for the ANN model [54,55]. For categorical outputs (i.e., Inadequate EAMT), the hyperbolic tangent activation function was used for the two hidden layers and the Softmax activation function was used for output layers. Figure 5 describes the typical components of the artificial neural network. The performance of the artificial neural network and logistic regression analysis were compared using the classification accuracy and receiver operation curve-area under the curve (ROC-AUC). In addition, independent variable importance generated from the multilayer perceptron tool was used to identify the most important variable in predicting the outcome. Table 5, below, shows the ROC-AUC values and their corresponding accuracy levels [56].

5. Conclusions

Providing adequate empiric antimicrobial therapy is considered one of the essential management strategies of sepsis. Our study resembles a situational analysis that describes the adequacy of EAMT provided to ICU sepsis patients and its determinants, which can potentially aid in improving antimicrobial prescription. We observed that more than half of patients received inadequate EAMT. Determinants associated with an increased likelihood of inadequate EAMT included APACHE II score, MDRO infections, and comorbidity (CAD), while a surgical history of lower limb amputation was associated with decreased odds of receiving inadequate EAMT. Furthermore, the study’s findings demonstrated that the ANN performed as well or better than logistic regression, which shows the potential utility for applying artificial neural network analysis in the prediction of outcomes in healthcare research.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12081305/s1, Table S1: Univariate and multivariate regression analysis of variables associated with inadequate EAMT.

Author Contributions

Conceptualization, A.H.H.D.A., S.N.H., N.O. and B.I.; Data curation, A.H.H.D.A. and O.E.A.; Formal analysis, A.H.H.D.A.; Funding acquisition, S.N.H., I.A. and I.A.A.; Investigation, O.E.A.; Methodology, A.H.H.D.A., S.N.H., N.O. and B.I.; Resources, O.E.A.; Supervision, S.N.H., N.O., B.I. and O.E.A.; Writing—original draft, A.H.H.D.A., S.N.H., N.O. and B.I.; Writing—review and editing, A.H.H.D.A., S.N.H., N.O., B.I., O.E.A., I.A. and I.A.A. All authors have read and agreed to the published version of the manuscript.

Funding

The authors thanks the Management and Science University, Malaysia, for extending a research grant (SG-001-022021-SPH) to publish this article.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board, General Directorate of Health Affairs in Madinah, Ministry of Health (no.: IRB54-2021).

Informed Consent Statement

Patient consent was waived due to the retrospective nature of this study.

Data Availability Statement

The data are not publicly available to keep confidentiality and to comply with ethical considerations.

Acknowledgments

The authors thank the Management and Science University for extending financial support to publish this research. The authors also thank Al Maarefa University, Riyadh, Saudi Arabia, for their support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gyawali, B.; Ramakrishna, K.; Dhamoon, A.S. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019, 7, 2050312119835043. [Google Scholar] [CrossRef] [Green Version]
  2. Bullock, B.; Benham, M.D. Bacterial Sepsis. In StatPearls [Internet]; StatPearls Publishing: Tampa, FL, USA, 2019. [Google Scholar]
  3. Sakr, Y.; Jaschinski, U.; Wittebole, X.; Szakmany, T.; Lipman, J.; Ñamendys-Silva, S.A.; Martin-Loeches, I.; Leone, M.; Lupu, M.-N.; Vincent, J.-L.; et al. Sepsis in Intensive Care Unit Patients: Worldwide Data from the Intensive Care over Nations Audit. Open Forum Infect. Dis. 2018, 5, ofy313. [Google Scholar] [CrossRef] [Green Version]
  4. Schmidt, G.A.; Mandel, J.; Parsons, P.; Sexton, D.; Hockberger, R.; Finlay, G. Evaluation and management of suspected sepsis and septic shock in adults. Uptodate Online 2018, 1–29. Available online: https://www.uptodate.com/contents/evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults (accessed on 16 April 2023).
  5. Al-Sunaidar, K.A.; Abd Aziz, N.P.; Hassan, Y.P. Appropriateness of empirical antibiotics: Risk factors of adult patients with sepsis in the ICU. Int. J. Clin. Pharm. 2020, 42, 527–538. [Google Scholar] [CrossRef] [PubMed]
  6. Garnacho-Montero, J.; Ortiz-Leyba, C.; Herrera-Melero, I.; Aldabo-Pallas, T.; Cayuela-Dominguez, A.; Marquez-Vacaro, J.A.; Carbajal-Guerrero, J.; Garcia-Garmendia, J.L. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study. J. Antimicrob. Chemother. 2008, 61, 436–441. [Google Scholar] [CrossRef] [PubMed]
  7. Ratzinger, F.; Eichbichler, K.; Schuardt, M.; Tsirkinidou, I.; Mitteregger, D.; Haslacher, H.; Perkmann, T.; Schmetterer, K.G.; Doffner, G.; Burgmann, H. Sepsis in standard care: Patients’ characteristics, effectiveness of antimicrobial therapy and patient outcome—A cohort study. Infection 2015, 43, 345–352. [Google Scholar] [CrossRef]
  8. Trifi, A.; Abdellatif, S.; Abdennebi, C.; Daly, F.; Nasri, R.; Touil, Y.; Lakhal, S.B. Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: Observational cohort study. Ann. Clin. Microbiol. Antimicrob. 2018, 17, 39. [Google Scholar] [CrossRef] [Green Version]
  9. Garnacho-Montero, J.; Garcia-Garmendia, J.L.; Barrero-Almodovar, A.; Jimenez-Jimenez, F.J.; Perez-Paredes, C.; Ortiz-Leyba, C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit. Care Med. 2003, 31, 2742–2751. [Google Scholar] [CrossRef]
  10. Niederman, M.S.; Baron, R.M.; Bouadma, L.; Calandra, T.; Daneman, N.; DeWaele, J.; Kollef, M.H.; Lipman, J.; Nair, G.B. Initial antimicrobial management of sepsis. Crit. Care 2021, 25, 307. [Google Scholar] [CrossRef]
  11. Fitousis, K.; Moore, L.J.; Hall, J.; Moore, F.A.; Pass, S. Evaluation of empiric antibiotic use in surgical sepsis. Am. J. Surg. 2010, 200, 776–782. [Google Scholar] [CrossRef]
  12. Nygård, S.T.; Langeland, N.; Flaatten, H.K.; Fanebust, R.; Haugen, O.; Skrede, S. Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: A prospective study in a Norwegian university hospital. BMC Infect. Dis. 2014, 14, 121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29, 1303–1310. [Google Scholar] [CrossRef]
  14. Kanji, Z.; Dumaresque, C. Time to effective antibiotic administration in adult patients with septic shock: A descriptive analysis. Intensive Crit. Care Nurs. 2012, 28, 288–293. [Google Scholar] [CrossRef]
  15. Leone, M.; Bourgoin, A.; Cambon, S.; Dubuc, M.; Albanèse, J.; Martin, C. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome. Crit. Care Med. 2003, 31, 462–467. [Google Scholar] [CrossRef]
  16. Micek, S.T.; Welch, E.C.; Khan, J.; Pervez, M.; Doherty, J.A.; Reichley, R.M.; Kollef, M.H. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob. Agents Chemother. 2010, 54, 1742–1748. [Google Scholar] [CrossRef] [Green Version]
  17. Moraes, R.B.; Guillén, J.A.V.; Zabaleta, W.J.C.; Borges, F.K. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: An observational study. Rev. Bras. Ter. Intensiv. 2016, 28, 315–322. [Google Scholar] [CrossRef] [PubMed]
  18. Oshima, T.; Kodama, Y.; Takahashi, W.; Hayashi, Y.; Iwase, S.; Kurita, T.; Saito, D.; Yamaji, Y.; Oda, S. Empiric antibiotic therapy for severe sepsis and septic shock. Surg. Infect. 2016, 17, 210–216. [Google Scholar] [CrossRef] [PubMed]
  19. Ahmed, M.; Yasrab, M.; Khushdil, A.; Qamar, K.; Ahmed, Z. Neonatal sepsis in a tertiary care hospital: Bacteriological profile and its antibicrobial sensitivity. Pak. Armed Forces Med. J. 2018, 68, 1654–1658. [Google Scholar]
  20. Arabi, Y.M.; Dara, S.I.; Memish, Z.; Al Abdulkareem, A.; Tamim, H.M.; Al-Shirawi, N.; Parrillo, J.E.; Dodek, P.; Lapinsky, S.; Feinstein, D. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology 2012, 56, 2305–2315. [Google Scholar] [CrossRef] [Green Version]
  21. Kazzaz, Y.M.; AlTurki, H.; Aleisa, L.; Alahmadi, B.; Alfattoh, N.; Alattas, N. Evaluating antimicrobial appropriateness in a tertiary care pediatric ICU in Saudi Arabia: A retrospective cohort study. Antimicrob. Resist. Infect. Control 2020, 9, 173. [Google Scholar] [CrossRef] [PubMed]
  22. Al-Ani, A.H.H.A.; Othman, N.; Hassali, M.A.; Ibrahim, B. Adequacy of Empiric Antibiotics Therapy and Its Impact on Outcomes in Adult Critically Ill Sepsis Patients: A Review. Malays. J. Med. Sci. 2022, 29, 17–23. [Google Scholar] [CrossRef]
  23. Kirişci, M. Comparison of artificial neural network and logistic regression model for factors affecting birth weight. SN Appl. Sci. 2019, 1, 378. [Google Scholar] [CrossRef] [Green Version]
  24. Eftekhar, B.; Mohammad, K.; Ardebili, H.E.; Ghodsi, M.; Ketabchi, E. Comparison of artificial neural network and logistic regression models for prediction of mortality in head trauma based on initial clinical data. BMC Med. Inform. Decis. Mak. 2005, 5, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Borzouei, S.; Mahjub, H.; Sajadi, N.A.; Farhadian, M. Diagnosing thyroid disorders: Comparison of logistic regression and neural network models. J. Fam. Med. Prim. Care 2020, 9, 1470. [Google Scholar]
  26. Faradmal, J.; Soltanian, A.R.; Roshanaei, G.; Khodabakhshi, R.; Kasaeian, A. Comparison of the performance of log-logistic regression and artificial neural networks for predicting breast cancer relapse. Asian Pac. J. Cancer Prev. APJCP 2014, 15, 5883–5888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Parsaeian, M.; Mohammad, K.; Mahmoudi, M.; Zeraati, H. Comparison of logistic regression and artificial neural network in low back pain prediction: Second national health survey. Iran. J. Public Health 2012, 41, 86–92. [Google Scholar]
  28. Marquet, K.; Liesenborgs, A.; Bergs, J.; Vleugels, A.; Claes, N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: A systematic review and meta-analysis. Crit. Care 2015, 19, 63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Kakkar, A.K.; Shafiq, N.; Sahni, N.; Mohindra, R.; Kaur, N.; Gamad, N.; Panditrao, A.; Kondal, D.; Malhotra, S.; Kumar, M.P.; et al. Assessment of Appropriateness of Antimicrobial Therapy in Resource-Constrained Settings: Development and Piloting of a Novel Tool-AmRAT. Antibiotics 2021, 10, 200. [Google Scholar] [CrossRef]
  30. Yokota, P.K.; Marra, A.R.; Martino, M.D.; Victor, E.S.; Durão, M.S.; Edmond, M.B.; dos Santos, O.F. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock—A quality improvement study. PLoS ONE 2014, 9, e104475. [Google Scholar] [CrossRef]
  31. Desai, N.; Gross, J. Scoring systems in the critically ill: Uses, cautions, and future directions. BJA Educ. 2019, 19, 212–218. [Google Scholar] [CrossRef]
  32. Ho, K.; Finn, J.; Knuiman, M.; Webb, S. Combining multiple comorbidities with Acute Physiology Score to predict hospital mortality of critically ill patients: A linked data cohort study. Anaesthesia 2007, 62, 1095–1100. [Google Scholar] [CrossRef] [PubMed]
  33. Zilberberg, M.D.; Shorr, A.F.; Micek, S.T.; Vazquez-Guillamet, C.; Kollef, M.H. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: A retrospective cohort study. Crit. Care 2014, 18, 596. [Google Scholar] [CrossRef]
  34. Masterton, R.; Drusano, G.; Paterson, D.; Park, G. Appropriate antimicrobial treatment in nosocomial infections—The clinical challenges. J. Hosp. Infect. 2003, 55, 1–12. [Google Scholar] [CrossRef]
  35. Carrara, E.; Pfeffer, I.; Zusman, O.; Leibovici, L.; Paul, M. Determinants of inappropriate empirical antibiotic treatment: Systematic review and meta-analysis. Int. J. Antimicrob. Agents 2018, 51, 548–553. [Google Scholar] [CrossRef] [PubMed]
  36. Lueangarun, S.; Leelarasamee, A. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: A retrospective study. Interdiscip. Perspect. Infect. Dis. 2012, 2012, 765205. [Google Scholar] [CrossRef] [Green Version]
  37. Zilberberg, M.D.; Nathanson, B.H.; Sulham, K.; Fan, W.; Shorr, A.F. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect. Dis. 2017, 17, 279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Zhu, H.; Chen, Y.; Hang, Y.; Luo, H.; Fang, X.; Xiao, Y.; Cao, X.; Zou, S.; Hu, X.; Hu, L. Impact of inappropriate empirical antibiotic treatment on clinical outcomes of urinary tract infections caused by Escherichia coli: A retrospective cohort study. J. Glob. Antimicrob. Resist. 2021, 26, 148–153. [Google Scholar] [CrossRef] [PubMed]
  39. Montravers, P.; Bassetti, M. The ideal patient profile for new beta-lactam/beta-lactamase inhibitors. Curr. Opin. Infect. Dis. 2018, 31, 587–593. [Google Scholar] [CrossRef]
  40. Antimicrobial Stewardship Subcommittee of the National Antimicrobial Resistance Committee and the General Administration of Pharmaceutical Care at Ministry of Health, Saudi Arabia. National Antimicrobial Therapy Guidelines for Community and Hospital Acquired Infections in Adults, 2018th ed.; Ministry of Health, Saudi Arabia: Riyadh, Saudi Arabia, 2016.
  41. Phua, J.; Koh, Y.; Du, B.; Tang, Y.-Q.; Divatia, J.V.; Tan, C.C.; Gomersall, C.D.; Faruq, M.O.; Shrestha, B.R.; Binh, N.G. Management of severe sepsis in patients admitted to Asian intensive care units: Prospective cohort study. BMJ 2011, 342, d3245. [Google Scholar] [CrossRef] [Green Version]
  42. Lin, S.-P.; Lee, C.-H.; Lu, Y.-S.; Hsu, L.-N. A comparison of MICU survival prediction using the logistic regression model and artificial neural network model. J. Nurs. Res. 2006, 14, 306–314. [Google Scholar] [CrossRef]
  43. Chen, C.-Y.; Chen, Y.-F.; Chen, H.-Y.; Hung, C.-T.; Shi, H.-Y. Artificial Neural Network and Cox Regression Models for Predicting Mortality after Hip Fracture Surgery: A Population-Based Comparison. Medicina 2020, 56, 243. [Google Scholar] [CrossRef] [PubMed]
  44. Strich, J.R.; Heil, E.L.; Masur, H. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. J. Infect. Dis. 2020, 222, S119–S131. [Google Scholar] [CrossRef] [PubMed]
  45. Corcione, S.; Shbaklo, N.; Vicentini, C.; Corradi, A.; Scabini, S.; Pinna, S.M.; Tarozzo, A.; Curtoni, A.; Cattel, F.; Cavallo, R.; et al. Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital. Infect. Prev. Pract. 2022, 4, 100187. [Google Scholar] [CrossRef]
  46. Panch, T.; Szolovits, P.; Atun, R. Artificial intelligence, machine learning and health systems. J. Glob. Health 2018, 8, 020303. [Google Scholar] [CrossRef] [PubMed]
  47. Rather, I.A.; Kim, B.-C.; Bajpai, V.K.; Park, Y.-H. Self-medication and antibiotic resistance: Crisis, current challenges, and prevention. Saudi J. Biol. Sci. 2017, 24, 808–812. [Google Scholar] [CrossRef] [PubMed]
  48. Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.-D.; Coopersmith, C.M. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016, 315, 801–810. [Google Scholar] [CrossRef] [PubMed]
  49. Degoricija, V.; Sharma, M.; Legac, A.; Gradišer, M.; Šefer, S.; Vučičević, Ž. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: Impact of intensive care unit performance and antimicrobial therapy. Croat. Med. J. 2006, 47, 385–397. [Google Scholar]
  50. Garnacho-Montero, J.; Gutiérrez-Pizarraya, A.; Escoresca-Ortega, A.; Fernández-Delgado, E.; López-Sánchez, J.M. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality. Crit. Care 2015, 19, 302. [Google Scholar] [CrossRef] [Green Version]
  51. Kumar, A.; Ellis, P.; Arabi, Y.; Roberts, D.; Light, B.; Parrillo, J.E.; Dodek, P.; Wood, G.; Kumar, A.; Simon, D. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009, 136, 1237–1248. [Google Scholar] [CrossRef]
  52. Landis, J.R.; Koch, G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33, 159–174. [Google Scholar] [CrossRef]
  53. IBM Corp. Statistics for Windows, version 25.0; IBM Corp: Armonk, NY, USA, 2017.
  54. AL-Rousan, N.; Mat Isa, N.A.; Mat Desa, M.K.; AL-Najjar, H. Integration of logistic regression and multilayer perceptron for intelligent single and dual axis solar tracking systems. Int. J. Intell. Syst. 2021, 36, 5605–5669. [Google Scholar] [CrossRef]
  55. Wang, A.; An, N.; Xia, Y.; Li, L.; Chen, G. A logistic regression and artificial neural network-based approach for chronic disease prediction: A case study of hypertension. In Proceedings of the 2014 IEEE International Conference on Internet of Things (iThings), and IEEE Green Computing and Communications (GreenCom) and IEEE Cyber, Physical and Social Computing (CPSCom), Taipei, Taiwan, 1–3 September 2014; pp. 45–52. [Google Scholar]
  56. Hosmer, D.W., Jr.; Lemeshow, S.; Sturdivant, R.X. Applied Logistic Regression; John Wiley & Sons: Hoboken, NJ, USA, 2013; Volume 398. [Google Scholar]
  57. Alam, M. Codes in MATLAB for Training Artificial Neural Network Using Particle Swarm Optimization; Research Gate: Berlin, Germany, 2016. [Google Scholar]
Figure 1. Percentages of adequate empiric antimicrobial therapy in sepsis patients as reported in the literature [5,6,7,8,9,11,12,14,15,16,17,18].
Figure 1. Percentages of adequate empiric antimicrobial therapy in sepsis patients as reported in the literature [5,6,7,8,9,11,12,14,15,16,17,18].
Antibiotics 12 01305 g001
Figure 2. Empiric Antimicrobial Therapy (EAMT)’s adequacy.
Figure 2. Empiric Antimicrobial Therapy (EAMT)’s adequacy.
Antibiotics 12 01305 g002
Figure 3. Receiver Operating Characteristic curves for the prediction of inadequate EAMT generated from the artificial neural network model. Note: AUC = 0.895.
Figure 3. Receiver Operating Characteristic curves for the prediction of inadequate EAMT generated from the artificial neural network model. Note: AUC = 0.895.
Antibiotics 12 01305 g003
Figure 4. Receiver Operating Characteristic curves for the prediction of inadequate EAMT generated from the logistic regression model. Note: AUC = 0.854.
Figure 4. Receiver Operating Characteristic curves for the prediction of inadequate EAMT generated from the logistic regression model. Note: AUC = 0.854.
Antibiotics 12 01305 g004
Figure 5. Structure and components of a typical artificial neural network (used with author’s permission) [57].
Figure 5. Structure and components of a typical artificial neural network (used with author’s permission) [57].
Antibiotics 12 01305 g005
Table 1. ICU sepsis/septic shock patients’ characteristics.
Table 1. ICU sepsis/septic shock patients’ characteristics.
VariablesTotal n (%), or Mean ± SD
Age (years) a67.6 ± 15.1
Gender b
  Male156 (61.7)
  Female97 (38.3)
Type of residency b
  Hajj/Umrah visitor13 (5.1)
  Local/resident240 (94.9)
Diagnosis b
  Sepsis113 (44.7)
  Septic shock140 (55.3)
History of antibiotic use b85 (33.6)
Admission site b
  Emergency department177 (70.0)
  Medical Wards2 (0.8)
  Surgical wards51 (20.2)
  Other institutes23 (9.1)
Surgical history b87 (34.4)
Time of surgery b
  Within the past week52 (20.6)
  More than 1 week–months12 (4.7)
  More than 6 months23 (9.1)
Type of surgical history b
  Abdominal2 (0.8)
  Orthopedic6 (2.4)
  Neurosurgery4 (1.6)
  Cardiovascular14 (5.5)
  Urological3 (1.2)
  Lower limb amputation41 (16.2)
  Diabetic septic foot debridement13 (5.1)
  Fasciotomy2 (0.8)
  Malignancy1 (0.4)
GCS score b
  Severe (≤8)58 (22.9)
  Moderate (9–12)144 (56.9)
  Minor (≥13)51 (20.2)
Number of comorbidities a2.3 ± 0.93
Type of comorbidities b
  Diabetes Mellitus213 (84.2)
  Hypertension214 (84.6)
  Asthma9 (3.6)
  Chronic Obstructive Pulmonary Disease5 (2.0)
  Coronary Artery Disease60 (23.7)
  Congestive Heart Disease10 (4.0)
  Chronic renal disease11 (4.3)
  Old malignancy5 (2.0)
  Liver diseases2 (0.8)
  Central Nervous System54 (21.3)
Need for Mechanical Ventilation b149 (58.9)
Number of organ failure a3.47 ± 1.78
  Liver failure b190 (75.1)
  Acute kidney injury b141 (55.7)
  Respiratory failure b153 (60.5)
  Central Nervous System b147 (58.1)
  Cardiac failure b121 (47.8)
  Disseminated intravascular coagulation b110 (43.5)
  Venous thromboembolism b17 (6.7)
APACHE II score a27.1 ± 8.4
Onset of infection b
  Hospital-acquired infection75 (29.6)
  Community-acquired infection178 (70.4)
Source of infection b
  Respiratory tract infection116 (45.8)
  Urinary tract infection45 (17.8)
  Abdominal infection4 (1.6)
  Soft tissue/skin infection65 (25.7)
  Surgical site infection21 (8.3)
  CNS infection1 (0.4)
  Unknown1 (0.4)
MDRO b78 (30.8)
GCS: Glasgow Coma Scale. APACHE II: Acute Physiology and Chronic Health Evaluation. CNS: Central Nervous System. MDRO: Multiple Drug Resistant organism. a: Data were presented as mean ± SD. b: Data were presented as number (%).
Table 2. Univariate and multivariate regression analysis of determinants of inadequate EAMT.
Table 2. Univariate and multivariate regression analysis of determinants of inadequate EAMT.
VariablesAdequateInadequateVariable Coefficient
(B)
Crude OR (95%CI)p ValueVariable Coefficient
(B)
Adjusted OR (95% CI)p Value
Type of surgical history b
Lower limb amputation32 (62.7)9 (25.7)−1.6310.196
(0.089–0.431)
<0.001−2.2150.109
(0.025–0.478)
0.003
Type of comorbidities b
Coronary Artery Disease15 (12.6)45 (33.6)1.2543.506
(1.831–6.710)
<0.0011.1403.128
(1.016–9.629)
0.047
APACHE II score a22.76 ± 8.1131.10 ± 6.590.1461.157
(1.111–1.204)
<0.0010.1001.087
(1.010–1.170)
0.026
MDRO b16 (13.4)62 (46.3)1.7135.543
(2.962–10.374)
<0.0011.9907.318
(2.839–18.864)
<0.001
APACHE II: Acute Physiology and Chronic Health Evaluation. MDRO: Multiple Drug Resistant organism. a: Data were presented as mean ± SD. b: Data were presented as number (%).
Table 3. Accuracy of ANN classification in training and testing sets.
Table 3. Accuracy of ANN classification in training and testing sets.
Classification
SampleObservedPredicted
AdequateInadequatePercentage Correct
Logistic regressionAdequate863372.3%
Inadequate3210276.1%
Overall Percentage 74.3%
ANN—TrainingAdequate641383.1%
Inadequate156080.0%
Overall Percentage52.0%48.0%81.6%
ANN—TestingAdequate28682.4%
Inadequate94182.0%
Overall Percentage44.0%56.0%82.1%
Table 4. Independent variable importance in determining EAMT adequacy.
Table 4. Independent variable importance in determining EAMT adequacy.
Independent Variable Importance
ImportanceNormalized Importance
Coronary artery disease0.13728.0%
Surgical history0.16032.7%
MDRO infection0.21443.9%
APACHI II score0.489100.0%
APACHE II: Acute Physiology and Chronic Health Evaluation. MDRO: Multiple Drug Resistant organism.
Table 5. Discrimination quality as defined by [56].
Table 5. Discrimination quality as defined by [56].
ROC-AUC ValueDiscrimination Quality
≥0.9Outstanding
0.8–0.9Excellent
0.7–0.8 Acceptable
0.5 No discrimination
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dala Ali, A.H.H.; Harun, S.N.; Othman, N.; Ibrahim, B.; Abdulbagi, O.E.; Abdullah, I.; Ariffin, I.A. Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis. Antibiotics 2023, 12, 1305. https://doi.org/10.3390/antibiotics12081305

AMA Style

Dala Ali AHH, Harun SN, Othman N, Ibrahim B, Abdulbagi OE, Abdullah I, Ariffin IA. Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis. Antibiotics. 2023; 12(8):1305. https://doi.org/10.3390/antibiotics12081305

Chicago/Turabian Style

Dala Ali, Ahmad Habeeb Hattab, Sabariah Noor Harun, Noordin Othman, Baharudin Ibrahim, Omer Elhag Abdulbagi, Ibrahim Abdullah, and Indang Ariati Ariffin. 2023. "Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis" Antibiotics 12, no. 8: 1305. https://doi.org/10.3390/antibiotics12081305

APA Style

Dala Ali, A. H. H., Harun, S. N., Othman, N., Ibrahim, B., Abdulbagi, O. E., Abdullah, I., & Ariffin, I. A. (2023). Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis. Antibiotics, 12(8), 1305. https://doi.org/10.3390/antibiotics12081305

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop